ANI Pharmaceuticals
PUBLIC
STATUS
201-300
EMPLOYEES
ANIP
STOCK SYMBOL
18
INVESTMENTS
$55.74
SHARE PRICE
(As of Friday Closing)
Description
ANI Pharmaceuticals Inc develops, manufactures and markets generic prescription pharmaceuticals, made in the U.S.A. It manufactures liquid, powder and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone, and Vancomycin.
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
- 210 Main Street West
- Baudette, MN 56623
- United States
+1 (218) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore ANI Pharmaceuticals’s full profile, request a free trial.
ANI Pharmaceuticals Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $36.92 - $86.96 | $674M | $55.65 | $1.37 | 195K | 12.1M |
ANI Pharmaceuticals Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 1,026,745 | 695,461 | 884,347 | 805,315 |
| Revenue | 215,703 | 201,576 | 176,842 | 128,622 |
| EBITDA | 75,605 | 68,551 | 56,312 | 42,348 |
| Net Income | 16,359 | 15,494 | (1,076) | 3,934 |
| Total Assets | 456,775 | 430,604 | 412,138 | 322,864 |
| Total Debt | 186,613 | 183,015 | 201,507 | 120,643 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
ANI Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore ANI Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookANI Pharmaceuticals Competitors (15)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lannett Company | Formerly PE-Backed | Philadelphia, PA | 0000 | 00000 | 000000000 | 00000 |
| 0000000 00000 | Private Equity-Backed | Pine Brook, NJ | 0000 | 00000 | 000000000 | 00000 |
| 000000 00000000000 | Formerly PE-Backed | Bridgewater, NJ | 0000 | 00.000 | 000000 - 000 | 00.000 |
| 0000000 0000000000 | Corporate Backed or Acquired | Hauppauge, NY | 000 | 000000&0 | ||
| 00000000 000000000 | Private Equity-Backed | Stockholm, Sweden | 000 | 000.00 | 000000 - 000 | 000.00 |
ANI Pharmaceuticals Investments & Acquisitions (18)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 000000 | 06-Aug-2018 | 000000000000000000 | 0000 | Other Pharmaceuticals and Biotechnology | 000000 0000000 |
| 000000 000 00000 ( | 07-May-2018 | 000000000 00000 00 | Buildings and Property | 000000 0000000 | |
| 00000 000000000000 | 07-May-2018 | 000000000 00000 00 | 00.00 | Drug Delivery | 000000 0000000 |
| 000 000000000 (00 | 04-Apr-2018 | 000000000 00000 00 | 00.000 | Buildings and Property | 000000 0000000 |
| AstraZeneca (NDAs and U.S. Rights to 4 Pharmaceutical Products) | 29-Dec-2017 | Corporate Asset Purchase | 000.00 | Other Commercial Services | 000000 0000000 |
ANI Pharmaceuticals Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000000 000000 | Other Pharmaceuticals and Biotechnology | Oakville, Canada | 0000 |
ANI Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore ANI Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookANI Pharmaceuticals Executive Team (9)
5 Former Executives
You’re viewing 4 of 9 executives. Get the full list »ANI Pharmaceuticals Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 000000 0000000 | ANI Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |